Carcinoma of the ampulla of vater: Comparative histologic/ immunohistochemical classification and follow-up

American Journal of Surgical Pathology

Volumn 28, Issue 7, 2004, Pages 875-882

  Zhou, Hui ^a   Schaefer, Nico ^a   Wolff, Martin ^a   Fischer, Hans Peter ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Carcinoma of the ampulla of Vater; CKT CK20; Immunohistochemical and histologic classification; Prognostic significance

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; KI 67 ANTIGEN; MUCIN 1; MUCIN 2; MUCIN 5AC; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; REPRODUCIBILITY; SURVIVAL RATE; VATER PAPILLA CARCINOMA;

AGED; AMPULLA OF VATER; CA-15-3 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; CARCINOMA, SIGNET RING CELL; COMMON BILE DUCT NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCIN; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; KERATIN-7; KERATINS; KI-67 ANTIGEN; MALE; MIDDLE AGED; MUCINS; NEOPLASM STAGING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3042801194     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200407000-00005     Document Type: Article

References (22)

1. Ajiki T, Kamigaki T, Hasegawa Y, et al. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater. Hepatogastroenterology. 2001;48:1266-1270.
2. Albores-Saavedra J, Henson DE, Klimstra DS. Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater. In: Rosai J, Sobin L, eds. Atlas of Tumor Pathology. Third series, Fascicle 27. Washington DC: Armed Forces Institute of Pathology; 2000:259-316.
3. Albores-Saavedra J, Menck HR, Scoazec JC, et al. Tumours of the gallbladder and extrahepatic bile ducts. In: Hamilton SR, Aaltonen LA, eds. WHO Classification of Tumours. Pathology and Genetics of the Digestive System. Lyon: IARC Press; 2000:203-218.
4. Barton RM, Copeland EM III. Carcinoma of the ampulla of Vater. Surg Gynec Obstet. 1983;156:297-301.
5. Beger HG, Treitschke F, Gansauge F, et al. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg. 1999;134:526-532.
6. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403-439.
7. Duval JV, Savas L, Banner BF. Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas and gallbladder. Arch Pathol Lab Med. 2000;124:1196-1200.
8. Fischer HP, Zhou H. Pathologie der Papilla Vateri. In: Seifert G, eds. Pathologie der Leber und Gallenwege. 2nd ed. Berlin: Springer-Verlag; 2000:1219-1257.
9. Fischer HP, Zhou H. Pathogenesis and histomorphology of ampullary carcinomas and their precursor lesions. Pathologe. 2003;24:196-203.
10. Goldstein NS, Bassi D. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of Vater adenocarcinomas. Am J Clin Pathol. 2001;115:695-702.
11. Kamisawa T, Fukayama M, Koike M, et al. Carcinoma of the ampulla of Vater: expression of cancer-associated antigens inversely correlated with prognosis. Am J Gastroenterol. 1988;83:1118-1123.
12. Kayahara M, Nagakawa T, Ohta T, et al. Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence. Surgery. 1997;121:611-617.
13. Kimura W, Ohtsubo K. Incidence, sites of origin, and immunohistochemical and histochemical characteristics of atypical epithelium and minute carcinoma of the papilla of Vater. Cancer. 1988;61:1394-1402.
14. Kimura W, Futakawa N, Yamagata S, et al. Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater. Jpn J Cancer Res. 1994;85:161-166.
15. Kitamura H, Yonezawa S, Tanaka S, et al. Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: their relationship to prognosis. Jpn J Cancer Res. 1996;87:631-640.
16. Klempnauer J, Ridder GJ, Maschek H, et al. Carcinoma of the ampulla of Vater: determinants of long-term survival in 94 resected patients. HPB Surg. 1998;11:1-11.
17. Matsubayashi H, Watanabe H, Yamaguchi T, et al. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of Vater. Cancer. 1999;86:596-607.
18. Monson RT, Honohue JH, McEntee GP, et al. Radical resection for carcinoma of the ampulla of Vater. Arch Surg. 1991;126:353-357.
19. Sobin LH, Wittekind CH, eds. UICC TNM Classification of Malignant Tumours. 6th ed. New York: John Wiley & Sons, Inc.; 2002.
20. Talbot IC, Neoptolemos JP, Shaw DE, et al. The histopathology and staging of carcinoma of the ampulla of Vater. Histopathology. 1988;12:155-165.
21. Vaidya P, Yosida T, Sakakura T, et al. Combined analysis of expression of e-erbB-2, Ki67 antigen, and tenascin provides a better prognostic indicator of carcinomas of the papilla of Vater. Pancreas. 1996;12:196-201.
22. Zhu L, Kim K, Domenico DR, et al. Adenocarcinoma of duodenum and ampulla of Vater: clinicopathology study and expression of p53, c-neu, TGF-alpha, CEA, and EMA. J Surg Oncol. 1996;61:100-105.